Received: from srvexch1.kliinikum.ee (192.168.20.105) by srvexch2.kliinikum.ee (192.168.20.104) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256) id 15.1.2375.31; Tue, 4 Aug 2026 12:36:15 +0300 Received: from DB5PEPF00014B9F.eurprd02.prod.outlook.com (2603:10a6:20b:21d:cafe::43) by AM9P192CA0005.outlook.office365.com (2603:10a6:20b:21d::10) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.270.18 via Frontend Transport; Tue, 4 Aug 2026 09:36:18 +0000 Received: from srvexch1.kliinikum.ee ([192.168.20.105]) by srvexch1.kliinikum.ee ([192.168.20.105]) with mapi id 15.01.2375.031; Tue, 4 Aug 2026 12:36:09 +0300 Received: from mail1.rit.ee (213.184.53.4) by DB5PEPF00014B9F.mail.protection.outlook.com (10.167.8.169) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.292.8 via Frontend Transport; Tue, 4 Aug 2026 09:36:18 +0000 Received: from AM9P192CA0005.EURP192.PROD.OUTLOOK.COM (2603:10a6:20b:21d::10) by PAWPR02MB9175.eurprd02.prod.outlook.com (2603:10a6:102:33f::10) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.270.17; Tue, 4 Aug 2026 09:36:19 +0000 Received: from srvexch2.kliinikum.ee (HELO outlook.kliinikum.ee) ([192.168.20.104]) by spamgwp8.kliinikum.ee with ESMTP/TLS/ECDHE-RSA-AES128-GCM-SHA256; 04 Aug 2026 12:36:16 +0300 Received: from PAWPR02MB9175.eurprd02.prod.outlook.com (2603:10a6:102:33f::10) by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS; Tue, 4 Aug 2026 09:36:22 +0000 From: "Karit Reinson" To: "Info - SOM" Subject: =?windows-1257?Q?P=E4ring_Sotsiaalministeeriumi_immunoprof=FClaktika_eksp?= =?windows-1257?Q?ertkomisjonile_seisukoha_kohta_selektiivsele_BCG-vaktsin?= =?windows-1257?Q?eerimisele_=FClemineku_osas?= Date: Tue, 4 Aug 2026 12:36:09 +0300 Keywords: Mall Message-ID: <22adee4bbcea4443a552e9b9bfe8f064@kliinikum.ee> MIME-Version: 1.0 Content-Type: multipart/related; boundary="----=_NextPart_000_0081_01DD2411.61ECDD60" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQFUpjtOk6TYCi9uAkuBmmeCVZlOPA== Authentication-Results: spf=fail (sender IP is 213.184.53.4) smtp.mailfrom=kliinikum.ee; dkim=pass (signature was verified) header.d=kliinikum.ee;dmarc=pass action=none header.from=kliinikum.ee;compauth=pass reason=100 X-CSE-ConnectionGUID: C93fVwRYRR2wc5BaYMa/gw== X-CSE-ConnectionGUID: 1RpLBnW2SECTw06ewg50vA== X-CSE-MsgGUID: /ZpyyZI6S42R13xy6qRcgQ== X-CSE-MsgGUID: pVP3CHPzTMyaNtrmZtnohg== X-IronPort-AV: E=Sophos;i="6.25,204,1779138000"; d="png'150?scan'150,208,217,150";a="76703553" X-Amp-Result: UNKNOWN X-Amp-Original-Verdict: FILE UNKNOWN X-Amp-File-Uploaded: False X-ThreatScanner-Verdict: Negative X-IPAS-Result: =?us-ascii?q?A0FXBQDGsXFqe8piMrlahBaBBIEKXjQEC0kdAQEBiAeLP?= =?us-ascii?q?IJ8kgaGJodcCAcBAQEBAQEHAQMBNxcBAgQBAQMBA4R+jWoCHgcBOBMBAgECA?= =?us-ascii?q?QMCAwEBAQEBAQEBAQEBCwEBAQQBAQECAQECBAMBAQEBAhABAUJJhk8BDIJbO?= =?us-ascii?q?4IWLIENCQEfCAESAQERJxEBBSABAQEbDQUPAQ4MJgEEEgEGAgaCdYIiAlAHw?= =?us-ascii?q?RmBAYIMAQEGBAMCAn3bKYFgCQmBTYRYLWyCXw0BKhGBIgIBaoIDgUIhhEQ2g?= =?us-ascii?q?VVEh1SCBIYugiaBDIJpj2osgToDWSwBDxE1ExcLBwWBZgMqLy0yPDIdgSM+F?= =?us-ascii?q?wgtWBsHBYEdgSsshFMjGTZ8gS91SnUtahIXgRqDFQKCekMLB2Y9NxQZBAIBg?= =?us-ascii?q?TVABQUMBAEDBAYMBQECCxSKDBAhDYE6OSkghhejIYIMkzWEIolgNAeEIIFmD?= =?us-ascii?q?IghAoIMlUIuF4VbpRGTK4NqgXMjinSCc4QSg0qTMgIEAgQFAhg2gUkjgVwzG?= =?us-ascii?q?oNaCUcDFwIPji0WHIQwyy1HMj0BAQcCBw4DC4Fog3cIjDUuAYEdAQE?= X-Talos-CUID: 9a23:u99oYWPkecVGtO5DARN/0GQSJZoeX1bh0y+OLlC3VD53YejA X-Talos-MUID: 9a23:C1UWTAod8fe/sB0jGJQezylcDJxDw5y8NGUcmLMaocy2KSp3OzjI2Q== X-IronPort-Anti-Spam-Filtered: true X-MS-Has-Attach: yes X-MS-TNEF-Correlator: X-MS-Exchange-Organization-ExpirationStartTime: 04 Aug 2026 09:36:18.4000 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: dca1a9c6-225a-40c9-60e3-08def20bd61d X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: DB5PEPF00014B9F:EE_|PAWPR02MB9175:EE_|DB9PR02MB7817:EE_ X-MS-Exchange-Organization-AuthSource: DB5PEPF00014B9F.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id: dca1a9c6-225a-40c9-60e3-08def20bd61d X-MS-Exchange-AtpMessageProperties: SA|SL X-MS-Exchange-Organization-SCL: -1 X-Microsoft-Antispam: BCL:0;ARA:13230040|7149299003|82310400026|5073199012|4073199012|6049299003|13003099007|4053099003|6133799003|11063799006|5063699009|56012099006|10067099003|19002099009|8096899003|4076899003|18003699003|16102099003|55112099003; X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:et;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(7149299003)(82310400026)(5073199012)(4073199012)(6049299003)(13003099007)(4053099003)(6133799003)(11063799006)(5063699009)(56012099006)(10067099003)(19002099009)(8096899003)(4076899003)(18003699003)(16102099003)(55112099003);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 04 Aug 2026 09:36:18.2166 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: dca1a9c6-225a-40c9-60e3-08def20bd61d X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: DB5PEPF00014B9F.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: PAWPR02MB9175 X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.7756025 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0270.016 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710232)(4717077)(4999285)(920097)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?1jY3hncDWCrRncMVHWrnUY8TOPe2iy2SrofkINW49CUS49YV5r5g0alf+r+Y?= =?us-ascii?Q?Ic8oL1NNoVsh4B3Ni+KpolNPrVQcmmqINGjuIqB3fGlK2i8jFpTFZX1P/r2X?= =?us-ascii?Q?slYQqaS9ksu5ItVq//NrWPLhhSdVE954UWNezMi6hOMi8XH0z6DN6hJc2ON3?= =?us-ascii?Q?BtNltaItPl5ibf7g5LFIK1pdLzu4tyHwjjGaqwtLbC+gCLgwuM43fehX5d1j?= =?us-ascii?Q?XLg7ONqk1HcZGgX7t+MkcuF93DQuBvYsc0jUs+y7RLCzjAc9EKPwzEhDQiHQ?= =?us-ascii?Q?vkprZo3z3jJYpv4OhffPutYNOAW703Ik7uIA6TtBJIgYFu3zbsd+c5YnpoOj?= =?us-ascii?Q?bzYKvcui4vZMs6pyWFjJmC/u/a/gzu7Z5BoiGNQXgNHwj5fIpFh2ClH/UW7c?= =?us-ascii?Q?0qHvnTh8IJtyHTxlwt7YMVAvY2m8sTBdEcNjEucLmqSaUr9/AjW/0XpOjNVu?= =?us-ascii?Q?skhyB6z+3l2Ls8BT76PGKiVZuVoQm7MDLx8qXIL/2DnrOp5bBqKH59OIfIZ0?= =?us-ascii?Q?Ni6uqnV+xOST5INE1QV70yFuk43Blt+NsENN/v5iW0E7REKWWoK2pr6N/9HD?= =?us-ascii?Q?vpf/Dy+HCmRs/N6y4gAX7NncdWbsvJlPCqHxkjOV09IIFNkQnr5w71dw1lG5?= =?us-ascii?Q?IkHMRftTxuP3KDIF73LaT0EjbB364xjw6Vo+CrGnVdi0BhGB/QR6bp1ADFsN?= =?us-ascii?Q?zVsQ29+MOu1D32o2AOhJj6mepwZUgntdtbmKEJvuOyLry6zvHzd Mkplp8p8M?= =?us-ascii?Q?ypHDafY8WCGJmQ4P0D8pBIiWLbeq1WWFKuSYFGysaCho4LA/ZXds1nA9pCz2?= =?us-ascii?Q?jmvAIC7A9M5OpwQnAFdNg6JUF/ZKpfIAB+Rfw6ky0WolWvJXwWD6+d9ktneM?= =?us-ascii?Q?Uyh8I0DIbobpFC8oRwoWwjCliycKR4gbT+DGV92LwR6PCNnUnQHcpdVP+8k4?= =?us-ascii?Q?oKrdUsxck6b0XtiLdvoZoEgmpsY4hyZRHTo7ryxhfF8Ed7/pPsmwdSQkRBzS?= =?us-ascii?Q?4LY5ajyiqZbX2zT/P7TVb/nufeIp7RWufFaKscJarpH8UXnH8NQC/pPsSeIl?= =?us-ascii?Q?Q8uUJaPraPepILTN1Y7njR944YXyE8F/N6lNtIm/UsTzeCfTnS3xHOIAhCCo?= =?us-ascii?Q?d1PYlW7VAQlq+xMOw4n/lx0Scoxe+y/0UIuY9YlijYFmWDkH1cBceGhyDyQc?= =?us-ascii?Q?5H8nsvA3SIS3YfwEjFcwbLQm2z9z29Qu5AcdvxQMWADXX3ezsppFLofEdEXl?= =?us-ascii?Q?wHppM1KUA5pC9thHxr+jzFrkYNPtEHjmNzH6apWcZxI/qwvst2IYq1O1wc5k?= =?us-ascii?Q?z0jmGFex1idXYep+Gt6s3j7TmtcP6DfVc/savuHuZ9jMV4+VNU32zbmirJV9?= =?us-ascii?Q?ruEnonPeI+xW/t94TebPs4816B7wuYhQNjWPIsibGIjEkBQpi7w3ClCyMn/N?= =?us-ascii?Q?YuMAM12Omq0IuiGetVIwxAb2I2Z8cPBQQo46fTW8X/cTLE5PG+LLUrCzAwWT?= =?us-ascii?Q?YGbBjW/fEVbVDeXPIEC02OgHOwVbqaafj+uFw QhlfjX3AOEokptnwpS4VBu2?= =?us-ascii?Q?jB0QaZhAkmI5rfwiA/yeuQ2ioICTVjCh2XWrm+mnDxJLebs/RjUDf7+VWumE?= =?us-ascii?Q?VXZ6dMMS7VwTG+WW4aOkEC9KacVt+BbV0opDoA84yWUlfEvlJFnVOJgdTpQH?= =?us-ascii?Q?exhYLRYS5/gpLag6eNcnUyR8Dh4U+2Mo1kBq2rZ0Q9PG39Lh8GBMu9kdIymE?= =?us-ascii?Q?8fGYG0+FJJOKHvUbPrtAIXsjd2Lu4scjeDvQSKnTKFefzv45sIsVRGBwb08T?= =?us-ascii?Q?hKcDb27ptN4WzccVC5/IiiIRyJnzNRSHJwei59/gGpcbqCm2PqG4OgYksqh9?= =?us-ascii?Q?uizaKY4wLatMNVZ/yWFeeoOYldqTthz86N+uZaLpAkee7IKxKBm5NxoZOFOE?= =?us-ascii?Q?6gTVQdbBYFpdlxb0YqArpWqM5NgrU+yFWzgTmvpOEo0tlh7nlBv2Abr+3zn2?= =?us-ascii?Q?yG6dbywKl4GxWlOQXXf/dwcAi1nPQLbn41B5vdkmyCDedLhwSBqk19ILSf5h?= =?us-ascii?Q?mJXlTIKN/ZioEQ9e0lQA88DX3TMgzJ4Y5cu4Kw1ofrG+5GBYkTT9aVenyMHm?= =?us-ascii?Q?zL479to9Kf/347botYOt3AdThN8oh6unGOzEVmxLQ0UdJk23CFKR0ITrDF/e?= =?us-ascii?Q?ecdYUBgu0qBaUT/rJBUPuG21sJy3LvaZocVAsiNWwXhWRY3cyBCjuTwikqN2?= =?us-ascii?Q?U/Dzcar7KWCfs6qLCZ2hNNArrdwGu1vG393tIzU/EEJe0329laHWxPzRcCp0?= =?us-ascii?Q?3vykgm8zGDoXCLW5d3oaMdt PzZttavBuLkTmm5SOImdxWxtqHVrGD1t6SUzg?= =?us-ascii?Q?61amDpax1szheMRRiojhzJTML/vYu232fE90Od9lHumRHIiYTaHY/QWy3oPd?= =?us-ascii?Q?Csya51k5hexmVWJqcyHB+AKQ/hXMREPnpR7PIGsFTYL7q8r/Tng8RcSnZJly?= =?us-ascii?Q?goeTkPq/m3bTkEa5KxpP/DLjUxMUSDp3DGMVNfxL3DK2EJPkOIgu2CqJJqiS?= =?us-ascii?Q?DWvDPBBF/24s5yuuE4wGBTjK5KpZ5b4SveUgiydlX3xevcsFZyDmCVOCMVqR?= =?us-ascii?Q?427wL4754YpHMD2r31qhUMpYjH2BEts3hsMI4e047uG9EkNSK+AAc7VZBvfI?= =?us-ascii?Q?MB6NDm1mHOatoX2d6ap+dAUboE2sJRhLE01ZKwMhI7m8XieRt296PRjHFC3q?= =?us-ascii?Q?V2vjOH4cPltgOMa4ZUKY4AAkiFRDsUEARXCYy+/IbNZ/m6pucwk6id5qGsMA?= =?us-ascii?Q?avIxH4KFMk7DoSmqBebzHNyjDOuihrNSIbY3PJukEzVE3qeSlVXzTY9i?= Content-Language: et x-ms-exchange-organization-originalclientipaddress: 213.184.53.4 x-ms-exchange-organization-originalserveripaddress: 10.167.8.169 received-spf: None (mail1.rit.ee: no sender authenticity information available from domain of postmaster@spamgwp8.kliinikum.ee) identity=helo; client-ip=185.50.98.202; receiver=mail1.rit.ee; envelope-from="Karit.Reinson@kliinikum.ee"; x-sender="postmaster@spamgwp8.kliinikum.ee"; x-conformance=spf_only dkim-signature: v=1; a=rsa-sha256; c=simple/simple; d=kliinikum.ee; s=securemail; t=1785836177; h=from:to:subject:date:message-id:mime-version; bh=PVUAyduGXw0vlmunWqKg9qNiCRkkYefRx7nbtuDZSJA=; b=VhmOYmjB9U9f9rZ96VDC5JbsR9O/n0hum9nL1W7gK52rk33ewpvEPp1F PXuUO0POe5EMzOQ9mDoauUZjK8nHBUrgq047sp6pKpkiBR0Oe7i6xq7kL qhA12xLKXy/Zyvypjvnv+469FT5oiBFz8nh1vZrPoOtu0O69fZmdnBhgX s=; acceptlanguage: en-US, et-EE x-originating-ip: [193.40.49.26] X-OlkEid: 00000000D07AAE8E23CDBE4CA04D01CCD82FCB7E070034AD76187591974DBF6C4F76951C873A01000200000000005797C783AAECB34FA6C879FF487E64D900000000102D0000D5A81B8925D0C44082D4D433139D3F63 X-DisclaimerOO: 1 This is a multipart message in MIME format. ------=_NextPart_000_0081_01DD2411.61ECDD60 Content-Type: multipart/alternative; boundary="----=_NextPart_001_0082_01DD2411.61ED2B80" ------=_NextPart_001_0082_01DD2411.61ED2B80 Content-Type: text/plain; charset="windows-1257" Content-Transfer-Encoding: 8bit Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Lugupeetud Sotsiaalministeeriumi immunoprofülaktika ekspertkomisjoni liikmed Seoses ekspertkomisjonile esitatud ettepanekuga minna Eestis universaalselt BCG-vaktsineerimiselt üle riskirühmapõhisele selektiivsele BCG-vaktsineerimisele sooviksin paluda Teie hinnangut komisjoni seniste seisukohtade ja edasiste plaanide osas. Ettepanek käsitleb selektiivsele BCG-vaktsineerimisele ülemineku põhimõtteid, riskirühmade määratlemist ning rakendamise korraldust. Palun võimalusel jagada komisjoni hinnangut järgmistes küsimustes. o Milline on immunoprofülaktika ekspertkomisjoni praegune seisukoht Eestis universaalselt BCG-vaktsineerimiselt selektiivsele riskirühmapõhisele BCG-vaktsineerimisele ülemineku osas? o Kas ekspertkomisjon peab sellist muudatust põhimõtteliselt põhjendatuks ning näeb selle rakendamist realistliku arengusuunana Eesti immuniseerimiskavas? o Kui komisjoni hinnangul on selektiivsele BCG-vaktsineerimisele üleminek tõenäoline, siis milline võiks olla hinnanguline ajakava selle ettevalmistamiseks ja võimalikuks rakendamiseks Eestis? Minu huvi nende küsimuste vastu tuleneb vastsündinute sõeltestimise korraldamisest Eestis. Kuna olen üleriigilise vastsündinute sõeltestimise üks eestvedajatest ja uuenduste eest vastutaja, siis aitab ekspertkomisjoni hinnang meie meeskonnal paremini kavandada ja ajastada võimalikke ettevalmistusi vastsündinute immuunpuudulikkuse sõeltestimise piloteerimiseks Eestis. Olen väga tänulik, kui ekspertkomisjon leiab võimaluse oma seisukohti ja hinnanguid jagada. Lugupidamisega Karit Reinson kliinilise geneetika osakonnajuht, vanemarst-õppejõud vastsündinute sõeltestimise töögrupi juht SA Tartu Ülikooli Kliinikum Geneetika ja personaalmeditsiini kliinik Tel: +372 53319170 Sepapaja 12/1, Tallinn 11415 kliinikum.ee/geneetika ------=_NextPart_001_0082_01DD2411.61ED2B80 Content-Type: text/html; charset="windows-1257" Content-Transfer-Encoding: quoted-printable

T=E4helepanu! Tegemist on v=E4lisv=F5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte = avada.

Lugupeetud Sotsiaalministeeriumi = immunoprof=FClaktika ekspertkomisjoni liikmed

 

Seoses ekspertkomisjonile esitatud = ettepanekuga minna Eestis universaalselt BCG-vaktsineerimiselt =FCle = riskir=FChmap=F5hisele selektiivsele BCG-vaktsineerimisele sooviksin = paluda Teie hinnangut komisjoni seniste seisukohtade ja edasiste = plaanide osas. Ettepanek k=E4sitleb selektiivsele BCG-vaktsineerimisele = =FClemineku p=F5him=F5tteid, riskir=FChmade m=E4=E4ratlemist ning = rakendamise korraldust.

 

Palun v=F5imalusel jagada komisjoni hinnangut = j=E4rgmistes k=FCsimustes.

o   Milline on immunoprof=FClaktika = ekspertkomisjoni praegune seisukoht Eestis universaalselt = BCG-vaktsineerimiselt selektiivsele riskir=FChmap=F5hisele = BCG-vaktsineerimisele =FClemineku osas?

o   Kas ekspertkomisjon peab sellist = muudatust p=F5him=F5tteliselt p=F5hjendatuks ning n=E4eb selle = rakendamist realistliku arengusuunana Eesti = immuniseerimiskavas?

o   Kui komisjoni hinnangul on selektiivsele = BCG-vaktsineerimisele =FCleminek t=F5en=E4oline, siis milline v=F5iks = olla hinnanguline ajakava selle ettevalmistamiseks ja v=F5imalikuks = rakendamiseks Eestis?

 

Minu huvi nende k=FCsimuste vastu tuleneb = vasts=FCndinute s=F5eltestimise korraldamisest Eestis. Kuna olen = =FCleriigilise vasts=FCndinute s=F5eltestimise =FCks eestvedajatest ja = uuenduste eest vastutaja, siis aitab ekspertkomisjoni hinnang meie = meeskonnal paremini kavandada ja ajastada v=F5imalikke ettevalmistusi = vasts=FCndinute immuunpuudulikkuse s=F5eltestimise piloteerimiseks = Eestis.

 

Olen v=E4ga t=E4nulik, kui ekspertkomisjon = leiab v=F5imaluse oma seisukohti ja hinnanguid jagada.

 

Lugupidamisega

Karit = Reinson

kliinilise geneetika = osakonnajuht, vanemarst-=F5ppej=F5ud

vasts=FCndinute = s=F5eltestimise t=F6=F6grupi juht

=

SA Tartu =DClikooli = Kliinikum

Geneetika ja = personaalmeditsiini kliinik

Tel: = +372 53319170

Sepapaja 12/1, = Tallinn 11415

kliinikum.ee/geneetika

=

3D"cid:image001.png@01D8596E.0E4D6F20"

 

 

------=_NextPart_001_0082_01DD2411.61ED2B80-- ------=_NextPart_000_0081_01DD2411.61ECDD60 Content-Type: image/png; name="image001.png" Content-Transfer-Encoding: base64 Content-ID: iVBORw0KGgoAAAANSUhEUgAAAOsAAAAtCAYAAABPu5x8AAAAAXNSR0IArs4c6QAAAAlwSFlzAAAO xAAADsQBlSsOGwAAABl0RVh0U29mdHdhcmUATWljcm9zb2Z0IE9mZmljZX/tNXEAACYeSURBVHhe 7ZwJnBTVtfBPVVf3dPfsjKjDIBpU4hZc0KARo2h8iTEaYz6/LBpNvoeAEhAFlbhQtrtGEAXDMI9E SYIxMW5RE7eIgpEkioqKRFQQkBkWhx6me7p7pqurvv+91T0LDDCov6cmffk10111695zzz3bPUtZ sVhMiq2IgSIGPvsYsD77IBYhLGKgiAGFgSKzFumgiIHPCQaKzPo52agimEUMFJm1SANFDHxOMFBk 1s/JRhXBLGKgyKxFGihi4HOCgSKzfk42qghmEQO7xKyXLWoe6DjBASJZw7IiG8PPDFt9bWy5uzM0 2jNSpRKWQfSrEnEyImXvx8aa8Z09V7xfxEARA10Y6BOzjnt+0xlhI3RhVszhRsCtEAlI1utoc058 cdUli2SRKYEHbjuu4q/dEQuDVkrUOV3E+LZE3KPEMGpFzKB4qlfbertBnpSOjumxn9a8XtyQIgaK GNg5BnbIrN+f3xys3cucVWpFR5uGIW1OVnLiK9KAGKWhgHVI0LQOybrOBZNf2PJiOOfcFHg28rzs 4ZwvEXO8GCX7+CA4Ip56Lq+EDXNPMULnSShwll3feklsbMWcnYP6v9vDrk/1E6PjMfHM6wD+UjGN 6bHRFY8VoLBt2yD7S4se1bb+/b8Lbe+zfRZh+izg5fMKww6Ztf9A41floeg5iY6UOJ4nYTMgpWYI ZWmI47qScR1py2XF4F+FFfqKa7qPPnZ0++pz10X23uzAmC4Wr2pGQCtVvvCBvt0sf9r4GYxKoKTe bmjJxUZXzf1MIbFpWIvU/kNZC+sBe6G46VUiFWLPbTlBvPLpUnfxrfaMdY9JafV0MZyHpXr0c/ac 1oUsbHFsTOX4j7MWu77lOxKovFq8LZeJm3tVAuU3SS7zO4Tagp2Na9tTDamb/H0xyi+V2kkX2TOa V0hp+XWSc+6WSPxVaa+cwQY8g+D54/bGshtSI8Uwz5acexmCdjjz3yBe4lKe6WE97QyW4v1PFgPb ZdZxC5rPrQ5Hz2ltT6EPPamySqTFyazv8HLPw27tXDoQbTu0ygqXtHdkpCWbkYBpyqkVgb2fCabl e2sMeacdBrVgVLejWbz2VwB9LRy6B8T/NZGSEq75q/ECM+25qedjo6LvbL08e35VSJLvPyiGVQWT t8Hc/SSXfTo2tvKKvqDCrm8eBLFdDbE/AbE/0LdnWveRAS83YA08Hhtb9SraPyKB6mn2rNRkscwS CYYPl1yiVsLVYfDwbcwNGBmGNkLDQE2yL3PssI8pA8QsYQ7pJ1awmjnOpP+bfDqZlXX1x3KZL5J7 BeEwBYF3hhjRy6V28uVsWIUEed5LVEo42A+cfwemWyjp8L/ENM8UL5dgrO0yq7jOUAmEvy3Scb2Y spuGxWvr/7HXVRzgY2GgV2aduri5ZLMpVzq5HPTiSSWMmnKzf2DjJtxxXL8NhRkvWdA6RFJtpzZX lVw9oLWjujXkShwNfHhY5PEvBOS777uvvNHu3SIZ67nYxOjGwnMQ/+Fi5OZD3AeK14HWLQ2Lk5rE /bHbrGYFpFeniNT7kViVx4rb/gAm6av2vHVhSVTvJ2F3N3HMd2Jjo+vUszamuySC+wJrraSsZRDr N2HWUeJlEva8ksdF4iWSgAk2DVgrQ94LSDwyACt9M/Bt6ZzbEYg8ejIMqUyBO0jKPErM8q+Luenn /E5rmKF65vzQntV8EvfXSXW4VDJYDCLanEDrlsPMAyUTXx2bWJfCrN5LLHdfcdqXxcbWbOrExYx1 UfrB5OmNXH9bX3cF9wBzuGYQbfYu+EK4ZVf3xE2wFMEFjOmAFmjShnDJOuD6JQk7B/t4lRJZd9u/ YOCvcX2lxKclpf+kk8Rx9F7gV4hImeyHmVQDDlfHfhpVQoeW/TUb/xzC7X27ofVEPZaLGaWeqW8e KE4kCM7Ws+49C7jT13FOgJNG234zILWD9+Mh/BTtK1nXGtZwIJK7WjIr34xNPKT1Y1Htf+jDvTJr MiPDolZwSAoTtzQQlKTTsWz9B+45951do6mx0KaPrFhhTz2jZLdX10392Z/eloueelfagwHZjOrc P2TI6/s7uWtHVP9ha9xCBEpb/YBuf+f0i3aCGAw5xZ5REo1NRJV3a7FYC0RSNc2es6Wcy4eiXW/l +X/ac+QuCcp3MdU8VHqE8c7n+v2StH4vgeAp9GuBaP9bDG+UOMrxHBoj7ZtgVvmKlITRQO8dJIlI Hd+fEStpc/22rmktjuZK63s+LK4AIDxoqsO3tuVVUwxYKyXlykRukHjwOoloes5oYq3b5wXxHMyK 6qMwa8diGdwCA7SjDT0Y4ByY8GlgPliiVQ+gwdFa4RC/57CGyczjH+5NSdhzmw+Bxp8Vp1XBd2MX jFkXZlY/N0rb+1Mwe/tLruX42MSaNOPAvDTHTcCow8Qqe1rCyZ9J9eUPSon5vITcX9uLqyZLZMti yQX2F8NtkZBRDZy/wJJg/uAEMaMX2XNbv8ziC5ZCMww5DMG3mCVeDqMukkD0ObFSNzDTTayPI0BW IXqY1A28D9ydyrr4bQXsOYm32YcvIKDLJTp4sz2r9czYTyuWbk0Xxd87xkCvzAoNHBiGSdWZNMQ5 NZHruGdrRlXD2qceWCVLP/jTh9WlVZN+cKC8MbBC7nroHQm3pSXudEh1KHrU+IWb5838ar/ztgYD olxqz4kvEiNysq+pZKCUxetEtjWF889G9HnXROup5lk3o7V+JuFwlXjGa1xQDHc/vHQQjJqVdPYw iTd9KLWD9kIeDENLzpQy5wVJWN8VyyqF7QIQnCWmFYXhGXuXG8CkLTGqqpkTQRLnt5InkoRYr4Ap h8LEXyFkVSpmaDaM+zia7zzO6S+L592DNoR4t8CA3hcl3V4n0eA4CVRcgaa+R0JBZaYqbvXECQYl iEYSxtm6eUhTkeNgiO9JTjF6DQyTf07/4XkX7aqOEKg94DXFqKjmWpmsWAbslYcC198kHToFQfMw zDfJnpe6XlwvIAHmzFpBMR3WleNxl+NLcDpHmnekadBMqX1/BExdKjnPx51BWM7THdWPIxi3VdLB AyTScSPC5qcIkm+hnTeIFXlJrNYL6LStFbXLW/Cf9UCvzAoFlPj4h5Qwa5HfH/SKFjN8lVRX7iPN CNBoWO4ZOWjdGS+vm/ett1JXOAHUAufYMjN47sTnW+bNOL7q2W3HMNcqZ5UfzjHQW47yQvWxOWUS 7Xcd56898sSCFtMtzadd4vvGY7GanP2LZKPicCT7utjZNe1oD4NnoO8gs0KI6rtPjb21Tm/vdu/r 5/1BaMoEHikSPFuc5HWxC6oXo0VPFxP54sQXwEzNWAjPYv7/P0msOQQED4Ool6ANG+mn8HMFjHo0 zLRZgZxveRiNbWH0/XVKnTOvoeLYvTVcDvpRpa39sQzWa4U9yeS4ZqY5AiSAazk3TgR7ZRwzsv4z ilHVU8oMlht4bjB+hgOUtWM35AjD0cfMw+VhuqNa/f4aD5Yet75juW+SuxsRoqu0n8LwOCgV265i oFdmhU44U/iWmKGYSYzD+A/TpqvZpx6xtwQC4ySBlYRjSX9SmQlLa70Hv/qOUVNtlYyJw6xBeDAp WaX1tmVWQ77kh3TUHMruDOIi3klzpd2P4Qb+CY8tIbRyNsTwAIDu3u1JQ6obYfxoB0Sv3NfqVkHq 55kaZ5UE8x6ubebEwc16PA2caggAzT3qvx0lgZgQKqcAtwTNxDlU9XY70OEKP775bHgFgaT8di6g 5fcgm2dPzPpunLpjbGD+SO5vMPy7EqyeajfEf4BX/XdMWjDVd4bNwprycGne7EVAaRpYDU4G49lH k8vb4gYMGFX1L3gJea7HtPkfKnxAczi05JUA/bYnHPsC739sn969wa680ppt9wKGaWRyjlJ+P5y6 aN211x5X13WeNM0fS2V5WDa3cKRUVmDi4dhjrzzoE2R4SsJpPy1iWgNacx2EXK2vXrKo+ejpx9Vw RvUb5yrMKOtITEMVwuFKxwoZOgAnEeP11jyIWoWAhPNkOF0pZk0Zpt8yafp5I2GUKCSWN2UVMxg+ gahmujnNeBIYitMnKpGyuJgIdq/tJBgJs5AxDd+S6GyWNCE7Utw7ES/r9/FWIxAUTeKkkY4v+nBo FoSp+aNg0+sOMG8Or613Pd7j++yGjZdLJjOTdSo/3ZmYuE9IqOSbmJKr5NC935TX338RT+t3wMVh mKpnaXlicqZ05ej8HApwf478hW5Q5q/n8JJXzJBc8lLgnIGD7UHMU+JpyguvuT7frxu8rpGHFwnr ur7w8LjGkUcEp5qHC99fo2I4k/Or0q7TEaxJMSP/wzr+iuNOO/RonMlbD4BIlJmurBqf8b3CHriF sbpgKeCrB9KLP3aGgV6Ztfq5O5fHR170t3IrOKLFaZfqYHiv5vbcRAbTDg576oEBedU9S9oxbwJs aqod88pSjgbdZh4XbRm/oGNWeUnwxjQOyjBHn5Zs9v9yq5NZ0T4xznUQhmJWwPCy98eOUc6k7TTT aMXs2oyIDkjTnWul9uI7IMpzZMAlxwMEKZC5Z/wnjWb+g/mqdYQJ0+tvIpv/SQ7HeRI1HoUJZ8Lk J8B4dwNDh7ipJhhpRfdZtZd3buu54lp3on1/R782yaUuxfmyGrPuIB8OUwkumJDvhoclwnyew3XP i42u/D3ncZxb0UkSjtwrbtv38XjPIgkE54yHN934kVqrvSw0CWapgzEI+8BabuJnaEbl/f2KHhcr AjHg+PNhoPRs/ty4uVXqpt2QuVEC/S6XtsSPWPRmfc8yQUC7MmnV822cnwvw+p5vz/2QedU9xWBb /H4RhJuT9J+3HARLhn4KFs7RFvFj4xjO0DNk7ZozpbZuNufxn6AoT2YPsBScRf647IFvCqvW5o+F ky7I/B0KX9Lled/uhhdvbI2BXpn1WjJzxi/YdDsbMwLVIykyl6LB0JUXLGh+fPbImqWyJPJFCOEA zawR+CKRejX2+Csvdx88aOXuSzgZGzO4JIdy88Q4fipZP2psvIoTJFB2ok6aUFrVTcOI1o6TIlLW rRI27pSmbDKfOTQRb+ytDFCHKbwhNrZsjZ4/nThNqqsNaZyClI+JCpPYdvMIGRyok/iWjSqMQq/h MN0QGD8obc0fcG0b4omNqngATfyUhGsJScQ/7Ay3lCMUEt5+Uo7mXTEiK7XL9pNMG2fk2zMSnsD3 AUgfeKRxzSkyeFi1xCXD2e2POG6ekWxwoAQ3vRs7r04TMnHlVWQZHS21VxLCcuIIgya9hvLs7yXh PsocSVnR5ErtQftJpD/r6Wa1N41o9OduYr4qiY2uud6u9+7i2Gji50ry/JPSNNB3VNVuBt4s8N7R IbXX8Exze2x0XTsw7S/xagQk46barpJwxXXSdOgWGbxylqTTv5Smla0yJLFaEsN5flBb7OyWDnAy mFATptT9hGliF7IHSoDXSMYEt3n408mvI7x8M7g8dzds/nucUsBSy1oUzJVKiBS5cRcxsN2kiOrn Zj0UP3HCoupg5LjNHWmpDJREIwF5YOpNLx1tTxw5SDZh3qjzKs5KDKVtMlsweVf99LnNb1RY1pEZ mBX9O0S8bwTsPVtHEh/Eq5iPAqkjjZu+LTYm6hPqdhoEr0wsPjWdPVRMjx/q03VtYl0+htf1Ijgc TWqy94WAbaHFxobQpspaxsTb7px1ithxvHSb0w9f4VFT17glqiBBjavn47tPhLHYIdi07R92znde tIXvfLpg8PvplMW3fFj8phxh/OGj5tBzd47b2UcXUBTmzj831sjDpX/zvJpSNdVPjXNt/rsPQ0zD lIfXF2J81Jp0nIrPIeq7Ol8ilf2xEGwKJ3x8/LIHyvnYwwFJn844atda1PPqo2ApMmp+Y3bpz3aZ VWnAC55tHpcyO/5eagWjW5Q5bIX3lS8N/MvXnlr9xjOHY3kq55N2KJq9JuPjf3jTMgNHkpwIs3rW aV884BbMrdE8x09o3uSYmUstIQZIsgH1AcVWxEARA9vFwA5zg2efWPPG+AXN51eGrPlhzpVxqtv6 hUJHHrGu7chnhuaPl4Q0pcbqod0Ks1WFvPXKxfGvtCc3bQqEn2oLXSImglozKuaz52zifPPDgllY 3KciBooY2D4Gdsis6rGZI2vuJU94j+pQyfSAigjk0pLpDCvSgTisPNJ4AOGUVyS+MqHMPzySKqWv xtojMGhtzpDfbg6QBUXfQMH0Vd5YnDEd7ulksvRw7hQ3q4iBIgZ6x8BOmVU9dtfImtvHP9+8ORoI /YJgerQyXcg6hFEtzOCFG2eR23uN1O5FneoWvIeBKkzdPa/cQGYPDlcdQNCRAL6QXSg5FShvP5ta 1lc/TxtDscFwLPomKU9vIK1xFgLniu55vn1Zi/b0irWKs94Oz+h9Geuz1IekjpMQ3Gd83Iqj7mvC I78fx6wp0njMaCqgyGG2QuQvq4KGHTZwfBB9TdXXx3eW3PGufOwec8xIkcPtHCZNw1+MxZZ3xn95 7uv4Vk+Kjamg8qir2XNa5uLQ/IVEEm9JuvwoMvEWAedg6GI3lQa7PcAY72j2fS1Zd1vIO8cRWHIx NOB74vvY+sSsaqyZx9fMu2BB67L+HZnp+6fkOJUsoZSqEBuXvaL8CPQnlEKOK78NdUPlDrB2xaSk sUoORo1wz20n4dz8GcjbJUBZ7D6MezVhnlImxr3s3qZyjPu4zo/UDS9yUOoCE6QkNBdnzBYEz/c4 nz8nsu8T+KtOYEEfIRPHO5ckffKl/72YFQQrr5VKmPgEm0XeeBY8n0Ua3T9OFquDtEsYUAkG163G e9575ZAlJ4NjPHYwtuFSxBG8G6A6iyd6AFjm7EHK5DipXkJVWLQrKccyB0kuB4Nt1TzzBHTOfCqY qHeWC7lLuMolLm4cyvftMiu0S6zeeQwv+QtiZEfiKu3yKPYRY31mVjXe7JEVL0+1px2/8oyZ48x2 d2ZOZS3lYMwvVeHMVBk/MKVOduG/DHavqkJR3+vw9B9YsV5e3nQWIZEX+ghbZze/HCzwFGP/luQc EG/g2jR15YhqmOCUq5EKF6leEjuv3a96WVxlydI1hyHNSHFY+ZLvnc33n4UktKw9kGzEPbuaTqwn eZXrfhiqPyEqz5kiaedl6kQXSvWUKyWedmRwXCUA4ArnMI43mflV9lRC4oRtahv35ftu+FNfyXuw ey43k5ws8YOBsUVVsCDcIkOIQW7srTxQr6M+pdII9+azXMV/O9dgE+uuXUKivazNe2R9XOiQVKYc QbYk//wxpHFukE23rYrFrtXZSfbcjuHsz8auKhs9DyEqBw1hrS1ct/05qJ7R63mN9WhiJnxTIWXV B6BN2pl7aR4mZW51ErvWig6lfpJVVUYUAaSO4L6qynmtJ865bjHOqOiyrfbiAPZ4KHuelCEXKTrV oT1gooDwH+eT6FLCmM8q7eS/Nsg6DPip8EEIBhNzCEn5oaN024ROfPuvFxpKv44CfogXr5LqwecX 1tYJg8o8676e+lSdNN3SKAMm4Qk3A6ypkXlH6/6Rff4omxof6tyb+hQVRs5uvL7ozc7XF6WTl0s8 jpd2MLTrbUU78WQ+pNgdBdt83yVmVU8rL7GR3Twrl3Wo2ijZWzKs6WAE3v6lq+Sd1qCEyeLJuK2y T2mFHFazuxwAo574BbbbfSJ2z+JdZlQNsRm4ACb9ABNLxR5UW9uJmIaWU8ldIjE89IZkNl5m1zvj pHzfjZJc/TQb+joSrR3z/GoQqzZE5eCOkqD3NTUG+bDjSTYfo3NYG1qvRgjsR/8Wrv9YGo+eIHWL j8KJjQR0viND7lwsyY7ZZO78VVYeNF8GLDYkE2mmKma4RIgBp4OnS+2awwH2HCRvhtwCG4K9EOH0 bg+sh0v/QL87bHvaUzLgYrKOPLKIcgchKFS9LUkYXY1rZ0OseM/Np0ksuIq85tvRJk8QH91TBvx9 GnGzNWieofT7Jc8+iIlG9UuI2lP5C4RMeqBzF9lTzWJ5LQiam+wZsE8kO5fY9kYJZgez5keo/vkV fy/QxeaGPM31Yxnvz4w3A9MTYWBiCRBriTjXgNvxXP+XREvHoNlq1at6gKkJmC4BaiS1trVg/Jbr mJesLA+BERhHUb5Kq1yjjkZ2/ZY2aZo2TuROKpNW/xxrjPR/Z3fmRBhV3KArlgbsdQfwqHcaZFUW FuGfLGNSHGFUogGvYZ/2VczKmzyOsOdSSxzOzsbCo7Kng6yq6M3SXj6ZayomdwUZa7+VcOM0uz78 lkSzf8GqI+01UA5Ml0k4cZ70H0TsO3s3AugUGGbrxBO9GRztiCXrjKxL9QW3PWPXm3XgktRO+aq0 rTlXwp4SRhdCOw3QaxXf36Ge+Aa73riKdS2UcNkcqS1/CIXyZ8lsMMhdb7Yb1oykqvAq8cL/h/5d 2YE9CKbrxy4za+ejhvcYVuA4KkZE+pWhdo96Qo6YfLHUfqeUupic3HPsIukX3V0yKuWXWGw85aci frSGOWLoDCW7PnkqhFCBSfqqjFgDQva6TALOKKWZfKRal9NtEp99SZHjDFUTB4FPci45iw35JUg7 n1S/Y3UGUX38Ad4TdQ7pc0+haU8CqSfoOeZs+RuMeoqsu32e1F1yiXgVN+iEgDkGmsIt52zj2nPI YCpL7y+54O0wx2X5etgXeVx9GKP1PvLgz+Xr1B5LhmDpzxg6vqrPQxDqlyHsu3HMzVaE2dnf9EiW kJWx0WUkPJCeKVJv21XPSO0WXjPjLY2Njt6KsBgqOetekiseIu3yUMy/B2Ojqhp4owVF8cZR9Blc GM9uSE6E+KuIaZ/t15fKI1T//Fa8VooKcm+SeRXj+jGYjvMULGSK/R04tfXBeu5h7aP4OpksK0Jt ura1GovnHzoxQjF0oZkUKJjOwxqOhpafYHFNjI2p+oGuNU5aK6R2itLiR1HdMxBNSJqlxvly3mpx t9QN+i8EwcGxseUjtXb2RO8JjIpGkFplrdCXuH4uDBzPIGhscpSDsfMjZFflM05dD+1l+EcUhW+V q92R6UcGVWlsTPkUf76Wt2Dq49h3mDzLvuY1cddmKc1MZhjKwDWORSCfrvaMubmOgKEgjbJCnqO5 bjkwoEl1O4LifRsB9jjPXoUAU3tMhpq3O5GPMrEalaOnDYFNENu7WbKhCVgyxJ533j46s+bIOEq2 XUi5Ii9nIlchGv6JbJxTH5u98HX7+1++WILRL8lGLIZSELillVeLDHlyRyb9DkFVeaamLjBVub4E ZHMXsvh35YXBk0A0TqySIRAZZwkL5JEqt2lZSCKlSlIpczWOhF6v09PLyg/EbHfkjQ++YS91B6Bh LBDtkQZ4FAMn2fgz6EX6nwnDeEigCcSDtWHvny90ZYmKPSkioIzMseYDTwxC1BaD7wWn1M3wgNGq VY6Nbdbl6eJdXQwAzJzxvFN02qVo872r1safhDVrZSUIpsXy4l5kADXuD2HsA8E08vyPCIHtBT7Y 7LMoIjCSEJZ25Uky93dMw012Q/rX0pG9Bq/7SojoWM7cOiUQwbQcBmyTdCMmNpaQmFX6uYjKucKc 3RQBlrNMcHIhCrMGXwEMRu2sD/fBYAULIpImuUXNp3Kruxc4cF0nGqsGERikWOpkjywClXCdE+F5 znhBmKH1e8zdj3WmsFqqmIvURdM3KR1ysTprA9g3NltfV3nMeZclsz5MH97l1YalYdzgO23waajg vu4LvlUqpw9fuyrUV4KXaxuU4NLXPZX0sXVDGBvel3mes3j2zNh5lT2z3CxVseXXdmqa8FQ8UrcU OC4Ua6wF1mPz19X9nAzeNyevrw4zNrRjXAqj/mPbuXu/8pGZNfb4P1+zTzvij9Kv6iydzF8SCktj 2932GUfeJmn3Jsn6Od1aq7pyU+y++3pBSF/BNNYghdXZibS6it/ZDbyqxbMOgrByEBYbrTbbWStu +BppOnINphJnyGznNitswlQub0NQVQlIQBL4TcwnN3ohZ4p1SEBqK0lbxKMAwy8Tp/T3sbHGh/6Z UjXFR1tlOvkVMyT8m1/sXEXSqmfsOHXkMY4HmGndCgp6LNVNQvC88dGbLlnnJ5TrbWGsY2VTpkDg 2yLm/hGG1K5mmQ7lbdTfGu6edFqOsHlTIrtPj8Uqc0j9TqcFZXcbsCRO4mw5SULe0xwDRrAENoV0 sh21LGd83l0p8Vsy5F//QlcGhYNXcMYFn546J+6mfQc5a7JUpl+QZOAbnYUMvY+rBJAWQv55k+OD hbBSNbMCI1BJyb58IJnQSWhNjiCtFGnsLMXJU3urpZiui56ROlGiHuWS2Sft+YsRSAd1cLdnccbW sHm6umNHuED4qZxvGNnhbRoiKud8V5vir+5CTGTle0ozK8ZV+dbKuvlzXwf9yMyqJwhYU6Q1+U3M 4VJJoshCwSMgUBLXgY/8celXiR+l9QUZhnR/vK8g9dIvIHdj0v2BdyDd6js/KA0z0Zorb27lwM+i nTWYHc/7Ty7HAQI5+ZUdPsPyLgm0ZVQyiXc4w0AowSWF18Do+675MmbgeEIEjysTtwuCCASRRTuH C4JGjZnXfl5IPJXEnv0DzN6ISaY8joQJzB8oz7HdAMFD3L2u2rIoIMCD6HkrCV8RXlDmZBCzLa68 cd0fUevwLYo6vM8eEnzTmvcobl+Bdgqz5vxGFyxQrVU7tXP+DBaDib/HMQDHirmY8U6lz88JQ+EI w3qIDFgtbUh6TzGPapop+X4HOFvNnPLfej31+tzJPWcfNUfswiimKM61egSEowoRCcIXqmk0vjvh UBq/mxAyVWkClpL3Evt2AnjrSaye9xrjn8JnjljZVoRCHocwVwFGA4MWe6iAqPwrg8awzo2SOBRh TPVIQfPqKhFVy8e6elb7AJOu8VOfXvjARTpjvXnGLRQu3IuQOhmawUeg+qIIEPsoosJzncFJhsNa y5dDusoDm8erwom/N/l1BH8M7TwAXtcjcOb3SidbXfxYzBp7+J8rqWsdj6n7K40f9VFwqhTEMszf VDou7d6o2LU7fxH4joDFSbMIc+lGCTq/5c17L4FbCN1doLybdoM+E0yzG9oWgUjCOrn/wY1LgutG pEfEZzzDyKBZDUW8jMN5K/cw4yyE4Ct4ZhrIehkHxnype4kzkLzGGDBiuS1NwzbjyHlNjOQse4b1 YwoJWkF1wRRTWr1FyoLn8gK3J0A6bntDiYkb7blJ3gphDGfeh7dZl0Etp6MIweIMn/0W58gpVK6U sZ5middubX0ok+oY+tiMdzJjX6aTTupdCsFb77UbEvcAfxsa+i0sjrsYQ721TsMHPIdq55SqB/Rk NYKKsydhg0jHqfacFI6sLLnavF5VncUb1BsGlMmtmzILMSUuwpS8mDdZyDXM/yhjjaD/oyTkv855 S1UG3YYV8gH30fTK1OWtFJQw+UMofOfxZAKPmy+d0/fUq3KMUpj0EZiL9Sceg69WgMOsrN/7Sqlt Vo6z3zA+FT0lEHbOj0cb+vjgV/IYDvCEZ7Jn/8W8WAsGzjGvijvAd3MTb3VUllN+PcynyiR5WRcE 2c2J46X1dTfKdV7fuXUzeQlWzkUgViyBZmaDr7m8dugMwo8UnQRZs0owoDhCNb3WPGxqfXq+/HVe AtqFE39vtFleNmCDpNf8GAH0EGvFa7zz19x8LGZV81Jtc7f9rcP3k936XSFb2DMHho2qnF9s+La2 H8aefOPtbRDxES5AjGwOTioP17tl/krWvo+r/xDMYpwM9c2ngEC8cWRFlWdfl6YpvFPm8pPIqCK2 xjnexWRLxQFMVafg/axP/RU5dxAMs07WDsBb24I5VXUjSHsY84BQSfsqaYpt1g4Fe++zIM6h+bDM GMaBaDiSZpzTJL53e2xiy3s4RnD+RDwk/GzGWIDUVeGWcdI4jbXHeq4W5xIX8KBG12G+nSlRczha NiuZ1ptjsbou55J6ykWDmHi+XbzBGXN24aVzmO6sq+pkhMIJenCn4w1/ktAFkoxDHMAX6f+2pDf9 BmYvlcaBz/vvslKm6LDTpW7pSIy7DZ0JBiWha4kb+lZIJLuCiOTpem9HV/0SDbwQ4YI7XybixX3L x8lwcLJEncXQbuW/AZ5mCBkHYNwvgfTKx0myCWYBjmTiL7x6Z6EeTznmZjhnSn+/KgDv/vng60i+ ciZ2lvsw1ihny7dwLn1VS/6U+YoesyTE8cpPraHC6Gne4/RNSpt5QVzbh1QBwdSOxxsvmedasecF lZDxWzr4Q+mf3iJrB+ak+r1vS9NF4Jg9SYfO5i7htreglcFfl/jNeIILwQbuJDk3h9vxs+ij1wzg +ZP0b8zxkr5vS3m8VVYMYrzGb+g5Uol5wKA8w/58+pyurlv3EypCGKkWPF9S1SlZp2nzG9L4Qg7B +xa0eAIP5XN3O6Hu9cvHZla9mMdevdI+fRhkWHalLpnbkkxgFp8T+8sbJA98ci1vuuaLnmHCfMtn p2jE+k0zyPp81YiqDMHp0HXm5DeHP7SNbi3dxql4ix98lCPRZzKfgCogGNWvaxx1JuyqRFHf8zOr 0Abp0N3g0F/1+3wHXHIjUnWZNE5/TY2fj+0RSlBtqzOxumTgTPMkgWdUe5i3brFRZc/51/CFKVh1 HNYfx483V/jM032N2swPYcJ2WpH56ps8xL43mvXk1++/HjbvKCvgRI0R1Y6qQvNfdBfVmkYxb8Gc z8cPOzWXj7duz2HV+L96rh9rSjN45/gqKaX7b+Uw62r5I1B+DX6Fk26+gFNjq0tq7vwaOt+2qekI WunGqP5zxIy7kiSApzAfghJns08PPKf6doV8ur/FM7+/Ovbs741S9tvQJpZDL3vffbH5758Is2pg /rTkKvu0I1/SXr7WxCNo1KW9zPcffInAvhcgFhy6vvub/HeIEM/8MyZV1X8w0opL74aBT4xZNcM+ +vIj/FGfYtsKA/ma2nt3BTEq73RX+hf7/ntj4BNl1n9vVBVXV8TAp4uBIrN+uvgvzl7EQJ8xUGTW PqOq2LGIgU8XA0Vm/XTxX5y9iIE+Y6DIrH1GVbFjEQOfLgaKzPrp4r84exEDfcZAkVn7jKpixyIG Pl0M/H8qIw5TyYmpKQAAAABJRU5ErkJggg== ------=_NextPart_000_0081_01DD2411.61ECDD60--